Mammogen

We’re back from an incredibly cup-filling weekend at the San Antonio Breast Cancer Symposium (SABCS), and we couldn’t be more energized! It was an honor to connect with brilliant colleagues, dedicated advocacy groups, and the broader breast cancer community. These conversations reaffirm just how critical events like SABCS are for highlighting the importance of early detection diagnostics—something we at Mammogen are deeply committed to making a reality for women everywhere. As we continue our mission to push the boundaries of science and innovation, we’re reminded that collaboration, education, and shared passion are what move us closer to a future where no woman faces late-stage breast cancer. To everyone we met: thank you for your insights, your inspiration, and your dedication to this cause. Let’s keep the momentum going! #SABCS2024 #BreastCancerResearch #EarlyDetection #CollaborationMatters #TogetherWeCan #WomensHealth Marty Keiser Elizabeth Cormier-May Katherine Vigeant Nathalie Jean-Charles Michael Colbus

We’re thrilled to announce that Mammogen is heading back to the San Antonio Breast Cancer Symposium (SABCS) for the second year in a row! This year, we’re honored to present our poster: “A comparative analysis of model and age independence of a plasma-based real-time qPCR clinical assay for the noninvasive detection of stage I breast cancer.” 🗓️ When: Friday, December 13th ⏰ Time: 12:30 PM - 2:00 PM Being part of SABCS is a privilege, and we can’t wait to share our groundbreaking research while learning from and connecting with the incredible breast cancer community. Events like these inspire us to keep pushing boundaries in early detection science! We’d love to see you at our poster presentation if you're attending! Let’s collaborate, innovate, and move closer to a future where no woman has to face late-stage breast cancer. Marty Keiser Elizabeth Cormier-May Katherine Vigeant Nathalie Jean-Charles Michael Colbus

Heading into the holidays? 🦃🍗 It’s more than just a season for turkey, pie, and family traditions—it’s also a great opportunity to talk about family health history. 🧬 Why? Because knowing what runs in the family can be life-saving. Here’s how you can start the conversation: • Ask about any health conditions in the family, especially cancer. • Find out specific diagnoses—was it breast cancer? Ovarian cancer? Something else? • Learn the ages of diagnosis; this can be crucial for identifying patterns and assessing your own risk. These conversations don’t have to be heavy—they can happen naturally over coffee or dessert. But the information you gather can be invaluable, helping your doctors create a tailored plan to keep you healthy and informed. Knowing your family health history empowers you to take charge of your health. Whether it’s adding a screening to your calendar or simply being more mindful, every step matters. ✨ Start the conversation this holiday season. You might just give your family (and yourself) the greatest gift of all: a healthier future. Wishing everyone a Happy Thanksgiving! 🍗 #FamilyHealthHistory #HealthAwareness #BreastCancerAwareness #PreventionMatters #KnowYourRisk #EarlyDetectionSavesLives

📢 OUT NOW! 🏃🏻♀️ Run, don’t walk to listen to the latest episode of Welloff Podcast with Gina Simeone and Dr. Tara Chalakani where Mammogens CEO, Elizabeth Cormier-May talks about breast health, mammograms, breast density and so much more! Available on Spotify, Amazon Music, iHeartRadio, Apple and Google! #EarlyDetection #breastcancerawareness #breastdensity #podcast #iheartradio #breasthealth #mammogram #mammogramssavelives

📢 🚨 We need YOU! 🚨 Mammogen is gearing up to launch our groundbreaking clinical trial, but we can't do it alone. We're looking for individuals who may: 🎗 Have a family history of breast cancer 🎗 Carry an inherited gene mutation associated with breast cancer 🎗 Have dense breasts 🎗 Be interested in finding out more about eligibility **Please note you DO NOT have to meet all the indications listed! You might meet one of them, or all of them. Either way, we would love to have you sign up to learn more!** Your participation can help shape the future of breast cancer detection, and together, we can make early detection more accessible and accurate than ever before. Interested? Click the link below to learn more and find out if you’re eligible to join us on this journey! Let’s make history—one step at a time. 🌸 🔗 https://lnkd.in/eu-irq3P #BreastCancerAwareness #ClinicalTrial #EarlyDetection #BreastHealth #Mammogen #DenseBreasts #GeneticScreening #BreastCancerResearch #InnovativeHealthcare #LiquidBiopsy

We're Tired of Waiting. At Mammogen, we got tired of hearing about women being diagnosed with breast cancer at stage 3 or later. We got tired of watching women with dense breasts face limitations with current screening options. We got tired of other companies promising "early detection" while only identifying cancer at advanced stages. So, we decided to do something about it. We didn't just talk about change—we made it happen. Mammogen put its resources and expertise into developing a breast cancer detection platform that redefines "early detection" for ALL women. We’re committed to a future where every woman—no matter her breast density—has access to accurate, early screening that can make a difference. Real change is here. And we're just getting started. #EarlyDetectionSavesLives #BreastCancerAwareness #WomensHealth #ForWomenByWomen #BeTheChange

📢 We have a very exciting announcement to share! Together, Mammogen and Operation Breast Density have designed this t-shirt to spread awareness about breast density and the limitations it can present in mammograms. Every purchase fuels both organizations’ efforts in the breast cancer community. Wearing this tee isn’t just about showing support; it’s about starting a conversation. The more people talking about breast density, the louder the message becomes!! You could save someone’s life by sharing your knowledge!🎗️ Proceeds go toward empowering women with the knowledge they need. Help us make a difference—get yours today! 🔗 https://lnkd.in/ehfuAGib

🚨 Reminder! One week from today! 🚨 Our very own CEO, Elizabeth Cormier-May, will be a featured panelist at the upcoming Women in Medtech: Updates in Breast Cancer Diagnostics forum, hosted by MassMEDIC! 🩺💡 Join Liz alongside other industry leaders, Marissa Fayer (CEO & Board Director of DeepLook Medical, CEO & Founder of HERhealthEQ) and Jyoti Gupta, PhD (President & CEO of Women’s Health & X-ray at GE Healthcare), for an insightful discussion on the future of breast cancer diagnostics. 📅 Date: September 26th ⏰ Time: 1 PM - 2 PM ET Don't miss out on this powerful panel of women driving change in MedTech. Secure your spot now by registering through the link below!👇 🔗 https://lnkd.in/dvGHNYq5 #WomenInMedTech #BreastCancerDiagnostics #MedTechInnovation #HealthcareLeadership #Mammogen #MassMEDIC #WomenInLeadership #BreastCancerAwareness

🌟 Exciting Progress, but the Work Isn’t Done Yet! 🌟 Today marks a significant milestone with the MQSA FDA mandate going into effect. This mandate ensures that all women are informed about their breast density following a mammogram. While this is a promising first step towards empowering women with critical information about their health, there is still so much work to be done! 🔍 Breast density matters. It can mask tumors on mammograms, reducing the effectiveness of this crucial screening tool. But awareness alone isn’t enough. We need to educate women about what this means for them—and help them understand the next steps they can take to ensure they are fully informed about their breast health. At Mammogen, we are committed to a future where screening limitations due to breast density are a thing of the past. We believe every woman deserves to know all her options and to have access to the most effective screening tools possible. We’re proud to be working towards a future where breast cancer detection is no longer a guessing game! Let’s continue to push for progress together—because no woman should be left in the dark when it comes to her health. #MQSA #BreastDensity #EarlyDetection #BreastCancerAwareness #Mammogen #HealthcareInnovation #WomenInHealth

At Mammogen, we’re excited to celebrate the progress made with the upcoming MQSA/FDA mandate, ensuring that women across the country will now be informed of their breast density after their mammograms. This is a significant step forward in breast cancer awareness, helping more women understand the connection between breast density and cancer detection. But while this mandate is a milestone, there’s still work to be done. Many women may not yet realize that dense breast tissue can limit the effectiveness of mammograms, potentially masking cancerous growths. At Mammogen, we are committed to working towards a future where there are no limitations in breast cancer screening—where every woman has access to more precise, innovative diagnostics that transcend current barriers! Together, we can make this vision a reality. Let’s keep pushing for more advancements in breast cancer screening and detection, ensuring every woman has the information and tools she needs to stay ahead of breast cancer. #MQSAMandate #BreastDensityAwareness #BreastCancerDetection #Mammogen #WomensHealth #InnovationInDiagnostics #FutureOfHealthcare